Certified Home Nursing Solutions Urges Greater Community Support for Disability Home Care Services
Certified Home Nursing Solutions, a leading provider of home care and Developmental Disabilities Administration (DDA) services across Maryland, is raising awareness about the growing need for better community support for individuals with disabilities who rely on home-based care.
Following their recent interview featured in Inside Business & Community Care, co-founders Tasha Brown and Adrius King are advocating for greater public understanding of the unique challenges faced by individuals with disabilities—and the importance of community involvement in supporting them.
'Disability home care isn't just about medical tasks,' explained Tasha Brown. 'It's about creating an environment where people can thrive, live independently, and feel connected to their community. That requires more than just caregivers—it takes neighbours, employers, and everyday people being willing to help and include.'
According to the Maryland Developmental Disabilities Administration, more than 26,000 Marylanders with developmental disabilities currently receive state services, with thousands more requiring additional home-based care and support to live safely and independently. Many of these individuals depend on services such as job coaching, transportation assistance, supported living, and skill-building activities.
Certified Home Nursing Solutions offers a wide range of disability care services, from personal support with daily living to vocational training and respite care. But the founders stress that no care agency can do it alone.
'We've seen clients flourish with just a bit of community support,' said Adrius King. 'One of our clients gained employment because a local shop owner took a chance and offered flexible hours with job coaching. Another began participating in community classes after a neighbour volunteered to drive her. These small actions can change lives.'
The company encourages Marylanders to play an active role in supporting individuals with disabilities in their communities.
Simple actions people can take include:
Offer inclusive opportunities in local workplaces, schools, and events.
Volunteer for community transport programmes or support services.
Check in on neighbours with disabilities to offer friendship or assistance.
Promote disability awareness within social groups and local organisations.
Encourage accessible public spaces by speaking to local councils or businesses.
Brown highlighted that inclusion doesn't always require large-scale changes. 'Sometimes it's about small gestures—inviting someone to a local gathering, offering a lift, or just saying hello,' she said. 'These moments help individuals with disabilities feel valued, connected, and supported.'
King added that many people misunderstand disability home care as something separate from community life, when in fact, they are deeply linked. 'People often assume it's just clinical care behind closed doors, but it's much more than that,' he explained. 'It's about giving people the tools, resources, and relationships to lead fulfilling lives.'
With demand for disability services growing steadily, particularly for in-home care, the company believes now is the time for communities to step up and help bridge the gap.
'This isn't just a job for care providers,' Brown said. 'It's about making sure everyone has a fair shot at independence and inclusion. Each of us can play a role, whether we're business owners, neighbours, or just caring community members.'
To read more, visit the website here.
About Certified Home Nursing Solutions
Founded in 2016, Certified Home Nursing Solutions provides home care, DDA services, respite care, and healthcare staffing across Maryland. The company specialises in holistic, culturally sensitive support for seniors and individuals with developmental disabilities.
Contact:
Info@certifiedhomenursingsolutions.com
Media Contact
Company Name: Certified Home Nursing Solutions
Email: Send Email
Country: United States
Website:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
6 minutes ago
- CTV News
Poetry with purpose: Laurie Fischer's story
Winnipeg Watch Poet Laurie Fischer shares how his cancer journey inspired his writing—and how his latest book supports cancer care.
National Post
36 minutes ago
- National Post
Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to maintain patent in this country
In what Science magazine has dubbed 'Novo Nordisk's Canadian Mistake,' Ozempic is soon to come off patent in Canada, opening the door to cheaper generic copycats, after the drug giant reportedly failed to pay a few hundred dollars in annual fees to maintain the patent rights before the weight-loss drug became a blockbuster seller. Article content As Science reported, a patent, once lapsed, can't be restored. Novo Nordisk will continue to hold its U.S. patent until 2032. Article content Article content Ozempic was already the third most prescribed drug in Canada last year with 7,390,000 prescriptions dispensed, a 17 per cent increase over 2023, according to drug analytics research firm IQVIA. Article content Article content Several applications for generic semaglutide, the active compound in Novo Nordisk's injectable drugs Ozempic and Wegovy, are now before Health Canada. Last week, a U.S. telehealth service announced plans to expand into Canada next year and offer generic semaglutide at a significant discount. Article content Richard Saynor, the head of Sandoz, a global leader in generic and biosimilar drugs, told Endpoint News in June that his company has filed for approval for a generic semaglutide in Canada once Novo Nordisk's patent exclusivity expires 'sometime in Q1 next year.' Canada is the globe's second-biggest semaglutide market, Saynor told Endpoint News. 'You gotta ask why. I don't think Canadians are disproportionately large. There's clearly a dynamic, like insulin, with cross-border business,' he said. Americans with diabetes have crossed into Canada to buy insulin at much lower prices. Article content Ozempic and Wegovy cost about $5,000 per year. If money is no longer a factor, if chemically-identical drugs are cheaper and more affordable, 'that's going to change the calculus for many people,' said Justin Lehmiller, a senior research fellow at Indiana University's Kinsey Institute and co-author of a new survey exploring the impact that weight-loss drugs — formally known as GLP-1 agonists — are having on dating and intimacy. Article content The survey of 2,000 single Americans (aged 18 to 91) led by Kinsey with found eight per cent reported having used a GLP-1 medication for weight loss in the past year. Article content Among the GLP-1 users, 16 per cent said exes had reached out to reconnect, 14 per cent said they were getting more matches on dating apps and 12 per cent said they were going on more dates. The drugs seemed to be doing more to booster 'online dating success' for men than for women, the researchers said. Article content 'Some of the studies and research that I've seen suggest that men only match one in 100 times on dating apps where for women, it's more like one in 10,' Lehmiller said. 'An attractiveness boost for men, which often accompanies using these drugs, could translate into a much bigger impact for them in the world of dating.'
National Post
an hour ago
- National Post
Constellation Kidney Group Marks 50 Years of Dialysis Innovation, Introducing KidneyOne to Power the Next Generation of Kidney Care
Article content RICHMOND, Va. — Constellation Kidney Group (CKG), a global portfolio of businesses under Miram Solutions within the Perseus Operating Group (Perseus) of Constellation Software Inc. (TSX: CSU), proudly commemorates 50 years of dialysis technology innovation, honoring the legacy of Quantitative Medical Systems Inc. (QMS), founded in Oakland, California in 1976. Acquired by Perseus in 2013, QMS laid the foundation for what is now a global leader in integrated clinical, operational, and analytics solutions for kidney care providers. Article content To mark this milestone, CKG is unveiling a refreshed brand identity and introducing its next-generation product ecosystem: Article content Article content KidneyOne, a fully integrated dialysis management platform; CKG Intelligence, a powerful analytics suite, including the Renal AI predictive care solution; and CKG Exchange, a robust interoperability hub for the future, connecting data across the kidney care continuum. Article content 'Celebrating 50 years is a testament to the incredible legacy of QMS and the ongoing commitment of Constellation Kidney Group to empower dialysis providers with technology that makes a meaningful difference,' said David Abbott, General Manager of CKG. 'As part of the Constellation Software family, our ethos has always been to acquire and nurture vertical market software businesses for the long term, ensuring continuous innovation and lasting value for our customers.' Article content CKG's KidneyOne platform brings together its market-leading solutions into a single, unified ecosystem — enhancing workflows, delivering actionable insights, and helping dialysis providers optimize care, operations, and compliance across global markets. Article content 'KidneyOne gives providers a smarter, more connected way to run their dialysis operations while supporting better outcomes and reducing costs,' said Chris Lutz, General Manager, CKG US. 'By uniting best-in-class solutions with AI-driven analytics and integrated workflows in a single platform, we're defining the next generation of dialysis software built to scale for long-term growth.' Article content The 50th anniversary milestone reflects CKG's enduring mission to advance kidney care through purpose-built technology, reliability, and long-term partnership. Visit the company's updated website to learn more: About Constellation Kidney Group Constellation Kidney Group (CKG) is a global leader in dialysis technology, delivering purpose-built clinical, financial, and operational solutions that empower kidney care providers worldwide. Formed through the acquisition of leading software innovators beginning in 2013, CKG brings together decades of expertise in KidneyOne — an integrated platform offering modern EHR applications, data-driven intelligence, and seamless interoperability through CKG Exchange. CKG is a global portfolio of businesses under Miram Solutions within the Perseus Operating Group of Constellation Software Inc. (TSX: CSU), and is committed to advancing kidney care through innovation, reliability, and long-term partnership. Learn more at Article content Article content
